Ethical Compliance
GLAND PHARMA
Sector:
Healthcare
Industry:
Drug Manufacturers - General
Market Cap Class:
large
Revenue
3.4%
Debt
0%
Liquidity
16.8%
Revenue
Debt
Liquidity
3.4%
Non Compliant
Questionable
Compliant
Compliant
INR Crores
| Export incentives | ₹22.99 |
| Sale of Products ( Pharma ) | ₹4,144.44 |
| Other Income | ₹17.16 |
Questionable
INR Crores
Non Compliant
INR Crores
| Interest Income | ₹149.50 |
INR Crores
| Revenue from Questionable Sources: | ₹0.00 |
| Revenue from Non Compliant Sources: | ₹149.50 |
| Total: | ₹149.50 |
| Total Revenue: | ₹4,334.09 |
Formula
Revenue from Questionable & Non Compliant Sources
Total Revenue
≤ 0.03 or 3%
Calculation
₹149.50
₹4,334.09
= 3.4%
questionable
Rationale
The sum of revenue from questionable and non-compliant sources should not exceed 3% of the total revenue. This ensures that the company has tolerable reliance on unethical sources of revenue.
